NYSCF CEO Pens Editorial on Mitochondrial Replacement Therapy
NYSCF CEO Susan L. Solomon penned an editorial in Roll Call commending the approval of mitochondrial replacement therapy, or MRT, by the UK Parliament House of Commons...
The latest news and updates about NYSCF and our collaborators
NYSCF CEO Susan L. Solomon penned an editorial in Roll Call commending the approval of mitochondrial replacement therapy, or MRT, by the UK Parliament House of Commons...
On Tuesday, February 3rd, the UK Parliament will debate whether to approve the use of mitochondrial replacement therapy or MRT in the UK. This therapy, similar...
NYSCF – Druckenmiller Fellow Alumnus Dr. Bi-Sen Ding, of Weill Cornell Medical College, published in Nature Cell Biology on his latest work studying lung tissue regeneration....
NYSCF – Robertson Stem Cell Investigator Dr. Ravindra Majeti, of Stanford University, published in Nature Medicine on his latest work studying genetic susceptibilities in acute myeloid...
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, of Case Western Reserve University School of Medicine, is the recipient of the International Society for Stem...
NYSCF – Robertson Stem Cell Investigator Dr. Shuibing Chen, of Weill Cornell Medical College, and her team studied the development of human pancreatic cells using stem...
NYSCF – Robertson Stem Cell Investigator Dr. Jacob Hanna, of the Weitzmann Institute of Science in Israel, and his team discovered a critical role played by...
NYSCF – Robertson Neuroscience Investigator Dr. Winrich Freiwald, The Rockefeller University, published his latest work on macaque facila processing in Current Biology. The researchers identified a...
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden, MIT Media Lab, described in Science the newest technology developed in his lab for imaging biological samples. The technology,...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published the lastest research out of his lab investigating the regulation of neural cell differentiation...
NYSCF – Robertson Stem Cell Investigator Dr. Jacob Hanna, of the Weitzmann Institute of Science, co-authored a paper published in Cell describing the creation of cellular...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, analyzed the genetic patterns in cancer cells and found that disarray in the cellular on-off...
The 92nd Street Y in Manhattan hosted a panel discussion entitled, “Homo Sapiens 2.0: Genetic Enhancement and the Future of Humanity,” which covered current and future...
NYSCF – Robertson Stem Cell Investigator and 2014 NYSCF – Robertson Stem Cell Prize winner Dr. Marius Wernig, Stanford University School of Medicine, made a breakthrough...
NYSCF – Robertson Stem Cell Investigator Dr. Derrick Rossi, of Harvard University, published the latest from his lab on using a gene editing technique to block...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, of Harvard University, published his recent analysis of whole-genome buslfate sequencing (WGBS). This sequencing method allows scientists...
NYSCF – Druckenmiller Fellow Dr. Sandra Pinho, of Albert Einstein College of Medicine, was part of a team of scientists who recently discovered new insights into...
NYSCF CEO Susan L. Solomon responded to “The Trials of Stem Cell Therapy,” published in The New York Times on September 15, 2014 with a Letter to the...
NYSCF – Druckenmiller Postdoctoral Fellow Dr. Raffaella Di Micco of New York University School of Medicine was first author for a paper published in Cell Reports...
NYSCF – Robertson Stem Cell Investigator Dr. Kristen Brennand of the Icahn School of Medicine at Mount Sinai led a team of scientists that discovered that...
Neurology Today featured NYSCF – Helmsley Investigator Dr. Valentina Fossati’s latest research on multiple sclerosis in a larger story about Dr. Fossati and her personal commitment...
NYSCF – Robertson Stem Cell Investigator Dr. Gabsang Lee, of John’s Hopkins University School of Medicine, was senior author on a Cell Stem Cell paper describing...
Researchers at the Harvard Stem Cell Institute, led by NYSCF Chief Scientific Officer Dr. Kevin Eggan, discovered a new, promising treatment for ALS, or Lou Gehrig’s...
NSYCF – Druckenmiller Fellow Alumnus Dr. Marco Seandal of Weill Cornell Medical College published his latest research on how paternal age effects genetic mutations in Stem...
Nature recently featured a profile on the education, background, and dynamic cross-discipline work of NYSCF Scientist Dr. Giuseppe Maria de Peppo. Dr. de Peppo focuses his...